Streetbeat News

Products Services

PLTR

Palantir Technologies Inc (NYSE:PLTR) reported Q2 earnings in line with estimates, with a 13% YoY revenue increase to $533.32 million and earnings of 5 cents per share. The company also announced a $1 billion share repurchase program and raised its full-year revenue guidance to over $2.212 billion. The demand for its AI platform is growing, with discussions underway with over 300 additional enterprises for deployment.

Portfolio Pulse from Adam Eckert

August 07, 2023 | 8:35 pm

QGEN

Qiagen has received FDA approval for a companion diagnostic to Blueprint Medicines' AAYVAKIT in gastrointestinal stromal tumors. This approval could potentially increase the demand for Qiagen's diagnostic products.

Portfolio Pulse from Benzinga Newsdesk

August 07, 2023 | 8:32 pm

LCID

Lucid Motors has confirmed that it is on track to meet its 2023 production target of over 10,000 vehicles.

Portfolio Pulse from Benzinga Newsdesk

August 07, 2023 | 8:13 pm

CHGG

Chegg, an American education technology company, has expressed its optimism about the potential of AI in expanding its opportunities. The company believes that it is well-equipped to meet the current and future needs of students.

Portfolio Pulse from Benzinga Newsdesk

August 07, 2023 | 8:10 pm

CHGG

Chegg announced that it will integrate generative AI technology into its proprietary solutions to improve student outcomes.

Portfolio Pulse from Benzinga Newsdesk

August 07, 2023 | 8:10 pm

CHGG

Chegg's recent survey indicates that students view ChatGPT and Chegg as complementary tools, each with distinct use cases.

Portfolio Pulse from Benzinga Newsdesk

August 07, 2023 | 8:09 pm

PARA

PARAA

Paramount+ has reported a 47% increase in revenue and has reached approximately 61 million subscribers.

Portfolio Pulse from Benzinga Newsdesk

August 07, 2023 | 8:02 pm

ACB

YCBD

Benzinga has released a roundup of the latest cannabis product releases, including THC chocolates by KANHA, sexual wellness products by HIGH PRIESTESS, THC and entheogen gummy line by FLORA + BAST, 50% THC infused pre-rolls by Aurora Cannabis (NASDAQ:ACB) (TSX:ACB), cannabis-infused soda by The Drinkable Company, and hemp-derived THC + CBD gummy by cbdMD (AMEX:YCBD). Aurora Cannabis has launched its first high-potency infused pre-roll with over 50% total THC, while cbdMD has introduced its hemp-derived Delta 9 THC + CBD gummy line.

Portfolio Pulse from Joana Scopel

August 07, 2023 | 7:14 pm

HYMTF

NIO

NKLA

RIDEQ

RIVN

STLA

TSLA

VWAGY

WKSP

XPEV

The EV market is a risky venture with Tesla and Chinese EV makers leading the race. Lordstown Motors and Nikola Corporation have fallen behind, with the former filing for bankruptcy. Chinese EV makers XPeng, Li Auto, and Nio are advancing rapidly. Traditional automakers like General Motors, Toyota, Volkswagen, and Ford are investing heavily in EVs. Stellantis, formed by Fiat Chrysler Automobiles and PSA Group, is also committed to EVs. Rivian and Tesla are set to release electric pickups, with Hyundai partnering with Worksport for solar-powered technology.

Portfolio Pulse from Upwallstreet

August 07, 2023 | 7:08 pm

MNMD

MindMed (NASDAQ:MNMD) reported Q2 2023 financial results, with cash and cash equivalents totaling $116.9 million, a 17.8% decrease from Dec. 2022. Net cash used in operating activities totaled $27.2 million, and R&D expenses increased by 59.1% and 39.8% for three and six months respectively. The company is about to complete enrollment for Phase 2b study of LSD compound MM-120 for Generalized Anxiety Disorder (GAD), with topline data expected in Q4 2023. Another Phase 2a study is evaluating MM-120 on AD/HD participants, with topline data expected between Q4 2023 and Q1 2024. MindMed also licensed Catalent’s Zydis ODT technology to use with MM-120.

Portfolio Pulse from Lara Goldstein

August 07, 2023 | 7:01 pm